Gamifant for Primary Hemophagocytic Lymphohistiocytosis


Gamifant Product Image

Gamifant (emapalumab-lzsg, Sobi)

Indications: patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.

Dosage: 1 mg/kg as an intravenous infusion over 1 hour twice per week; Administer dexamethasone concomitantly with GAMIFANT.


Click here for more prescribing information

Related Videos
© 2024 MJH Life Sciences

All rights reserved.